In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin
-
Add time:08/27/2019 Source:sciencedirect.com
In this article, we have reported the inclusion complex behaviors and their pharmaceutical application of anticancer drug property of Etoposide with β-cyclodextrin. The inclusion complex is used to improve the poor aqueous solubility of the anticancer drug Etoposide. The aqueous solubility and in-vitro dissolution studies support to the anticancer drug Etoposide with β-cyclodextrin complex is significantly improves the aqueous solubility. Etoposide:β-cyclodextrin solid-state complexes were prepared by Physical mixture, kneading and solvent evaporation methods, and were characterized by FT-IR, 1HNMR, XRD, DSC and SEM techniques. In addition, the in-vitro antimicrobial and antibiofilm study of Etoposide drug is a sensible microorganism was significantly increased by an inclusion complexation process. The antibiofilm of anticancer drug Etoposide with β-cyclodextrin studies have been analyzed by confocal laser scanning microscopy.
We also recommend Trading Suppliers and Manufacturers of Etoposide phosphate (cas 117091-64-2). Pls Click Website Link as below: cas 117091-64-2 suppliers
Prev:Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) II: In Vitro In Vivo Correlations (IVIVC)
Next:Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationDetermination of Etoposide phosphate (cas 117091-64-2) intermediates by gradient liquid chromatography using postcolumn derivatization with cuprammonium hydroxide09/03/2019
- Micronization of etoposide using solution-enhanced dispersion by supercritical CO209/02/2019
- RESEARCHPhysical and Chemical Stability of Etoposide phosphate (cas 117091-64-2) Solutions09/01/2019
- Short communicationPhase I and pharmacokinetic study of a water-soluble etoposide prodrug, Etoposide phosphate (cas 117091-64-2) (BMY-40481)08/31/2019
- In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment08/30/2019
- Etoposide phosphate (cas 117091-64-2) or etoposide with cisplatin in the treatment of small cell lung cancer: Randomized Phase II trial08/29/2019
- Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study08/28/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) II: In Vitro In Vivo Correlations (IVIVC)08/26/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) I: In Vitro and In Vivo Evaluation08/25/2019


